Management of Acute Cardiogenic Shock at the New Brunswick Heart Centre

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1416 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-14

Study Completion Date

2021-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In Atlantic Canada, acute myocardial infarction occurs at a rate of 2.9 % of the population and is the most common cause of cardiogenic shock (CS). In many studies, acute myocardial infarction accounts for up to 80% of the patients with CS. While there are different methods of treating patients with CS, the rate of mortality has not significantly improved over the years and remains as high as 50%. Recent studies have shown that a multi-modal, team-based approach can help improve patient outcomes; however, such a standardized approach is yet to be implemented in the New Brunswick Heart Centre (NBHC).

The study aims to understand the difference in outcomes between two groups of patients treated for CS: SHOCK TEAM versus non-SHOCK TEAM. This is a retrospective study of 168 patients using the data from NBHC registry and patient charts. The study duration is 1 year. The primary outcome is hospital survival. Secondary outcomes include time from diagnosis to invasive monitoring and intervention. All data will be analyzed statistically between the two groups. The end goal of the study is to establish standard guidelines to treat CS patients and improve patient survival.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

National Cardiogenic Shock Initiative

NCT03677180

Cardiogenic Shock Acute Myocardial Infarction STEMI - ST Elevation Myocardial Infarction +2 more

COMPLETED

Guideline Recommended Care and Excess Mortality for Non ST-elevation Myocardial Infarction : A National Cohort Study

NCT02436187

Non ST-elevation Myocardial Infarction

COMPLETED

The Broken Heart Study II (BHS-II)

NCT04325321

Takotsubo Cardiomyopathy

ACTIVE_NOT_RECRUITING NA

EKG Criteria and Identification of Acute Coronary Occlusion

NCT03863327

Acute Coronary Syndrome STEMI STEMI - ST Elevation Myocardial Infarction +7 more

UNKNOWN

Mechanical Complications of Acute Myocardial Infarction

NCT03848429

Post-Infarction Heart Rupture Post-Infarction Ventricular Septal Defect Post-Infarction Mitral Papillary Muscle Rupture

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiogenic Shock

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

At- risk group (SCAI stages A, B)

Patients who had a SCAI stage A or B at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was compared with the cardiogenic shock group only for preliminary analysis.

Standard care

Intervention Type OTHER

No interventions were used, as this is an observational study.

Cardiogenic shock group (SCAI stages C-E)

Patients who had a SCAI (Society for Cardiovascular Angiography and Interventions) stage C-E at any point during their stay at the New Brunswick Heart Centre, Saint John Regional Hospital. This group was used for all subsequent analyses.